Southern Oncology Clinical Research Unit (SOCRU) is a leading Phase One cancer trial unit based in Adelaide, South Australia, recognised for its unwavering commitment to advancing cancer treatment through innovative research and exceptional patient care. Our multidisciplinary team includes highly skilled oncologists, research coordinators, nurses, and research staff, all working in collaboration to offer participants the opportunity to partake in cutting-edge first-in-human (FIH) clinical trials while receiving the highest standard of evidence-based care.
Reputable Directors
Under the leadership of our reputable Directors with extensive expertise in oncology and clinical research, our unit prioritises patient safety, comfort, and well-being. We are deeply committed to creating a compassionate, supportive environment where every participant is treated with respect and dignity throughout their journey.
Integrity and Compliance
Our research is conducted with the utmost integrity and in full compliance with Australian regulatory standards, including the National Health and Medical Research Council (NHMRC) Guidelines, Therapeutic Goods Administration (TGA) requirements, National Safety and Quality Health Service (NSHQS), and Good Clinical Practice (GCP). This commitment to excellence ensures that every trial is conducted with precision, transparency, and the highest ethical standards.
Proven Track Record
With a proven track record of success and a focus on continuous innovation, SOCRU is proud to be at the forefront of transforming cancer care, helping to shape the future of cancer treatment and making meaningful contributions to the global fight against cancer.
Our Core Values
Service
Serve our patients by providing accessible, responsive, and personalised care.
Compassion
Understand the needs of those we serve and respond with care.
Respect
Champion the rights of individuals to be in control of their lives and to be treated as equals.
Excellence
Hold ourselves accountable for achieving the best health outcomes for individuals and our community.
Integrity
Be open, honest, just, reasonable, and ethical in our relationships.
Transforming Research Outcomes
Our Journey in Clinical Research
December 2019
Establishment of SOCRU
SOCRU was founded by our directors to provide cancer patients in the southern region with access to phase one oncology clinical trials that were previously unavailable within local healthcare networks.
March 2020
First Study Activated
SOCRU commenced its first study, laying the groundwork for ongoing contributions to high-quality, patient-focused research.
August 2021
First GMO Study
We commenced our first genetically modified organism (GMO) study, expanding our research capabilities into advanced and regulated therapeutic areas.
July 2023
Partnership with the OMICO National Clinical Trials Network
We are honoured to be a partner of the OMICO National Clinical Trials Network, a leading collaborative research network that accelerates clinical trials for cancer patients. This partnership strengthens our efforts to contribute to cutting-edge cancer research, facilitating access to novel treatments and therapies across Australia. Learn more about OMICO here.
December 2024
Became a Member of the Australian Comprehensive Cancer Network
As a proud member of the Australian Comprehensive Cancer Network (ACCN), we actively participate in a national initiative that aims to improve cancer care through collaboration between healthcare providers, researchers, and policymakers. This membership allows us to be part of a powerful network working to set the standard for comprehensive cancer care in Australia. Discover more about ACCN here.
December, 2024
SOCRU Turns Five
Marking five years of growth, from advancing high-quality clinical research to expanding services and strengthening community support, all made possible by the dedication and passion of our exceptional team.
Learn about the dedicated professionals leading our efforts to drive innovation in clinical research and enhance patient outcomes.
Explore career opportunities within our organisation and contribute to groundbreaking clinical research that makes a difference in patient care.